On October 3, 2024 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, reported its participation at the 4th Annual Needham Private Biotech Company Virtual 1×1 Forum, taking place October 8-9, 2024 (Press release, Sapience Therapeutics, OCT 3, 2024, View Source;1-forum-302267194.html [SID1234647019]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Company management will participate in one-on-one meetings with investors during the conference.